FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2284547312> ?p ?o ?g. }

• W2284547312 abstract "Chemoreduction is the key treatment for retinoblastoma management. However, anticancer agents suffer from poor cell permeability and chemoresistance due to major interaction with multidrug resistant (MDR) efflux proteins (MDR1 and MRP2) over-expressed on retinoblastoma tumor. Ocular cells have shown good tolerability against antimicrobial moxifloxacin (fourth generation fluoroquinolone) at higher dose level. As majority of fluoroquinolones become ineffective due to efflux mediated acquired drug resistance therefore, we have first determined an interaction of moxifloxacin with efflux (MDR1 and MRP2) transporters. Our results provides direct evidence that moxifloxacin is an overlapping substrate of MDR1 and MRP2 efflux transporters. Since, literature has evident co-administration of overlapping drug substrate as a viable strategy to overcome MDR. Therefore, we have tested moxifloxacin potential to overcome chemoresistance in retinoblastoma. Our results showed that 2-2.5 fold increased uptakes of three anticancer drugs (etoposide, topotecan and vinblastine) were observed in the presence of moxifloxacin across model cell lines suggesting moxifloxacin mediated evasion of efflux pumps. Significant reductions in efflux ratio of these anticancer agents were also observedin the presence of moxifloxacin indicating moxifloxacin mediated improved anticancer transport. Following cytotoxicity study, tenfold reduction in IC50 value of topotecan and etoposide and twofold reduction in IC50 value of vinblastine was observed in the presence of moxifloxacin. Significant enhancement of anticancer mediated caspase-3 enzyme activity and reduction in proinflammatory cytokines (IL-8 and IL-6) release were also observed in the presence of moxifloxacin. There is a need to further explore this finding to confirm its clinical feasibility, if proven, ultimately it will aid to reduce the chemotherapeutic dose and associated dose-limiting toxicities. Considering the fact that most drug targets are indeed contained within specific intracellular compartments, the ability of a drug to accumulate into these sites is a critical determinant in the observed drug response. Mitochondrion is an attractive target for drug-delivery because there is a growing confirmation to support an association between mitochondrial dysfunctions and a number of ocular diseases. A range of possibilities exist for the selective drug delivery to the mitochondria one among such is a transporter targeted strategy. Localization of various influx and efflux transporters is generally considered to be restricted to cell surface level. However, cellular compartments may also be a potential site for these transporters. The functional localization of both efflux (MDR1) and influx (PepT-1) transporters in the mitochondrial membrane of primary corneal epithelial cells was studied. Isolation and purification of mitochondria was performed by optimized cell fractionation method. Functional activity of MDR1 and PepT-1 transporter was assessed by performing in vitro uptake studies on…" @default.
• W2284547312 created "2016-06-24" @default.
• W2284547312 creator A5074215288 @default.
• W2284547312 date "2013-03-15" @default.
• W2284547312 modified "2023-09-27" @default.
• W2284547312 title "Novel drug interaction for improving intracellular accumulation and efficacy of chemotherapeutics in retinoblastoma and mitochondrial localization of transporters in corneal epithelial cells" @default.
• W2284547312 hasPublicationYear "2013" @default.
• W2284547312 type Work @default.
• W2284547312 sameAs 2284547312 @default.
• W2284547312 citedByCount "0" @default.
• W2284547312 crossrefType "dissertation" @default.
• W2284547312 hasAuthorship W2284547312A5074215288 @default.
• W2284547312 hasConcept C104317684 @default.
• W2284547312 hasConcept C126322002 @default.
• W2284547312 hasConcept C133936738 @default.
• W2284547312 hasConcept C149011108 @default.
• W2284547312 hasConcept C185592680 @default.
• W2284547312 hasConcept C200082930 @default.
• W2284547312 hasConcept C2776694085 @default.
• W2284547312 hasConcept C2778119113 @default.
• W2284547312 hasConcept C2778589691 @default.
• W2284547312 hasConcept C2778836808 @default.
• W2284547312 hasConcept C2781209748 @default.
• W2284547312 hasConcept C36201501 @default.
• W2284547312 hasConcept C44312359 @default.
• W2284547312 hasConcept C501593827 @default.
• W2284547312 hasConcept C55493867 @default.
• W2284547312 hasConcept C71924100 @default.
• W2284547312 hasConcept C98274493 @default.
• W2284547312 hasConceptScore W2284547312C104317684 @default.
• W2284547312 hasConceptScore W2284547312C126322002 @default.
• W2284547312 hasConceptScore W2284547312C133936738 @default.
• W2284547312 hasConceptScore W2284547312C149011108 @default.
• W2284547312 hasConceptScore W2284547312C185592680 @default.
• W2284547312 hasConceptScore W2284547312C200082930 @default.
• W2284547312 hasConceptScore W2284547312C2776694085 @default.
• W2284547312 hasConceptScore W2284547312C2778119113 @default.
• W2284547312 hasConceptScore W2284547312C2778589691 @default.
• W2284547312 hasConceptScore W2284547312C2778836808 @default.
• W2284547312 hasConceptScore W2284547312C2781209748 @default.
• W2284547312 hasConceptScore W2284547312C36201501 @default.
• W2284547312 hasConceptScore W2284547312C44312359 @default.
• W2284547312 hasConceptScore W2284547312C501593827 @default.
• W2284547312 hasConceptScore W2284547312C55493867 @default.
• W2284547312 hasConceptScore W2284547312C71924100 @default.
• W2284547312 hasConceptScore W2284547312C98274493 @default.
• W2284547312 hasLocation W22845473121 @default.
• W2284547312 hasOpenAccess W2284547312 @default.
• W2284547312 hasPrimaryLocation W22845473121 @default.
• W2284547312 hasRelatedWork W1988867169 @default.
• W2284547312 hasRelatedWork W2018584825 @default.
• W2284547312 hasRelatedWork W2019490712 @default.
• W2284547312 hasRelatedWork W2056077439 @default.
• W2284547312 hasRelatedWork W2073055302 @default.
• W2284547312 hasRelatedWork W2098585473 @default.
• W2284547312 hasRelatedWork W2102110565 @default.
• W2284547312 hasRelatedWork W2114828347 @default.
• W2284547312 hasRelatedWork W2132940659 @default.
• W2284547312 hasRelatedWork W2133614390 @default.
• W2284547312 hasRelatedWork W2290860889 @default.
• W2284547312 hasRelatedWork W2553103457 @default.
• W2284547312 hasRelatedWork W258442487 @default.
• W2284547312 hasRelatedWork W2727579800 @default.
• W2284547312 hasRelatedWork W2888642241 @default.
• W2284547312 hasRelatedWork W3048180462 @default.
• W2284547312 hasRelatedWork W3163627135 @default.
• W2284547312 hasRelatedWork W3209291380 @default.
• W2284547312 hasRelatedWork W841818052 @default.
• W2284547312 hasRelatedWork W2586775760 @default.
• W2284547312 isParatext "false" @default.
• W2284547312 isRetracted "false" @default.
• W2284547312 magId "2284547312" @default.
• W2284547312 workType "dissertation" @default.